Development and evaluation of MMIRA-CRISPR/Cas13a-MBQD assay for the detection of influenza A/B viruses and SARS-CoV-2
Ning Yang(Nanjing Medical University), Yiyue Ge(Jiangsu Provincial Center for Disease Control and Prevention), Qiao Qiao(Jiangsu Provincial Center for Disease Control and Prevention), Junyan Ma(Nanjing Medical University), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Tao Wu(Chinese Academy of Sciences), Xiaojuan Zhu(Liaoning Normal University), Ying Chi(China Three Gorges University), Ge Hu(Beijing University of Agriculture), Kang-Chen Zhao(Jiangsu Provincial Center for Disease Control and Prevention)
Cited by 2
Related Papers
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204